PT  - JOURNAL ARTICLE
AU  - Cheng, Yafang
AU  - Ma, Nan
AU  - Witt, Christian
AU  - Rapp, Steffen
AU  - Wild, Philipp
AU  - Andreae, Meinrat O.
AU  - Pöschl, Ulrich
AU  - Su, Hang
TI  - High efficacy of face masks explained by characteristic regimes of airborne SARS-CoV-2 virus abundance
AID  - 10.1101/2020.09.10.20190348
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2020.09.10.20190348
4099  - http://medrxiv.org/content/early/2021/02/07/2020.09.10.20190348.short
4100  - http://medrxiv.org/content/early/2021/02/07/2020.09.10.20190348.full
AB  - Airborne transmission by droplets and aerosols is important for the spread of viruses and face masks are a well-established preventive measure, but their effectiveness for mitigating COVID-19 is still under debate. We show that variations in mask efficacy can be explained by different regimes of virus abundance. For SARS-CoV-2, the virus load of infectious individuals can vary by orders of magnitude, but we find that most environments and contacts are in a virus-limited regime where simple surgical masks are highly effective on individual and population-average levels, whereas more advanced masks and other protective equipment are required in potentially virus-rich indoor environments such as medical centers and hospitals. Due to synergistic effects, masks are particularly effective in combination with other preventive measures like ventilation and distancing.One Sentence Summary Face masks are highly effective due to prevailing virus-limited environments in airborne transmission of COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study is supported by the Max Planck Society (MPG). Y.C. thanks the Minerva Program of MPGAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicable.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is available in the main text or the supplementary materials.